NDC 50090-0811-01 - Tizanidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0811
- Requested NDC
- 50090-0811-01
- Package NDCs from labels
- 50090-0811-1, 50090-0811-3, 50090-0811-0, 50090-0811-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tizanidine - A-S Medication Solutions | A-S Medication Solutions | 2026-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0811-0 | Tizanidine | 30 in 1 BOTTLE | TABLET | 30 | 28 | |
| 50090-0811-1 | Tizanidine | 60 in 1 BOTTLE | TABLET | 60 | 28 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0811 | TIZANIDINE TABLET [A-S MEDICATION SOLUTIONS] | 28 | Current NDC, Legacy NDC, 2 package rows | 20250425_180985f0-3fbd-4868-a826-b84101618a03.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0811-0 | EA - Each | 50090-0811 | ecdc9428-787e-4b3a-917c-0330754ef9bb | 1 | 2021-08-05 |
| 50090-0811-1 | EA - Each | 50090-0811 | 1a611ee6-979e-4ffc-9e31-01333d9a288b | 1 | 2021-08-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Advagen Pharma Limited | 7f39499a-98cf-4d13-9b07-ccb5c22e43c8 | 2026-11-04 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | American Health Packaging | 3670f9e3-988d-48e6-9df0-d403d699e08a | 2026-10-30 | Warnings, Adverse reactions | ANDA076286 B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fd16a25c-67b6-ae6c-e053-6394a90aeee0 | 2026-10-28 | Warnings, Adverse reactions | 313412 313413 B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fdf4f09d-4537-a438-e053-6394a90a573d | 2026-10-28 | Warnings, Adverse reactions | 313413 B53E3NMY5C |
| Tizanidine | TIZANIDINE | St. Mary's Medical Park Pharmacy | cfd52c0c-a7c2-e23d-e053-2a95a90abbd1 | 2026-10-23 | Warnings, Adverse reactions | ANDA076286 313412 B53E3NMY5C |
| Tizanidine | TIZANIDINE | REMEDYREPACK INC. | 17ca23af-c88f-4235-930a-d7568051696f | 2026-10-15 | Warnings, Adverse reactions | ANDA076286 313413 B53E3NMY5C |
| tizanidine | TIZANIDINE | Cardinal Health 107, LLC | eeb18068-75c8-42d0-a006-1b134648333f | 2026-10-06 | Warnings, Adverse reactions | 313413 B53E3NMY5C |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ae9b6808-632f-4204-8581-bf146dcab69f | 2026-10-05 | Warnings, Adverse reactions | B53E3NMY5C |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 6439a7ef-1b22-4fa1-9be3-eedd3cd24191 | 2026-10-05 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | Preferred Pharmaceuticals, Inc. | 32c3be66-5398-425c-ac65-e57ba819bb43 | 2026-10-05 | Warnings, Adverse reactions | ANDA076286 313413 B53E3NMY5C |
| tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | f0e4eb26-6733-4df6-bb3c-86bf4d976f42 | 2026-10-05 | Warnings, Adverse reactions | 313413 B53E3NMY5C |
| Tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | 3c993e3c-ee52-45a7-be39-60eaac7a1092 | 2026-10-02 | Warnings, Adverse reactions | ANDA076286 313412 B53E3NMY5C |
| Tizanidine | TIZANIDINE | A-S Medication Solutions | 180985f0-3fbd-4868-a826-b84101618a03 | 2026-10-01 | Warnings, Adverse reactions | ANDA076286 50090-0840-3 50090-0811-0 50090-0840-4 50090-0840-7 50090-0840-2 50090-0811-1 50090-0811-3 50090-0840-6 50090-0840-0 50090-0811 50090-0840 50090081101 313412 313413 6326e649-3c83-4f2b-a275-baee5eee6288 180985f0-3fbd-4868-a826-b84101618a03 B53E3NMY5C |
| Tizanidine Hydrochloride | TIZANIDINE HYDROCHLORIDE | Apotex Corp. | 3dd09a0d-a782-1d6d-a552-b71e5bcbf2fe | 2026-09-18 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine | TIZANIDINE | Apotex Corp. | 01c0d3d3-2373-a1b7-822a-80a66291a248 | 2026-09-18 | Warnings, Adverse reactions | 313412 313413 B53E3NMY5C |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e19f83b8-8c59-415c-a744-7473d46ab0ca | 2026-09-16 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e94aa8b1-74ed-46b7-94c5-53d5d5630be6 | 2026-09-16 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | d7d5dce0-f8a2-404d-9e87-e2235f5d3268 | 2026-09-16 | Warnings, Adverse reactions | B53E3NMY5C |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.